Assessment of the Antileishmanial Potential of Cassia fistula Leaf Extract
Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol 24-c methyltransferase (LdSMT), trypanothione reductase (LdTR), pteridine reductase (LdPTR1), and nucleoside hydrolase (LdNH), were modelled, an...
Saved in:
Published in | ACS omega Vol. 6; no. 3; pp. 2318 - 2327 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
26.01.2021
|
Online Access | Get full text |
Cover
Loading…
Abstract | Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol 24-c methyltransferase (LdSMT), trypanothione reductase (LdTR), pteridine reductase (LdPTR1), and nucleoside hydrolase (LdNH), were modelled, and molecular docking was performed against the abundant phytochemicals of its leaf extract. Molecular docking results provided the significant prima facie evidence of the leaf extract to have antileishmanial potential. To confirm this, we performed in vitro antileishmanial and cytotoxicity assays. Methanolic extract of C. fistula leaves showed growth inhibition and proliferation of L. donovani promastigote with an IC50 value of 43.31 ± 4.202 μg/mL. It also inhibited the growth of intra-macrophagic amastigotes with an IC50 value of 80.76 ± 3.626 μg/mL. C. fistula extract was found cytotoxic at a very high concentration on human macrophages (CC50 = 626 ± 39 μg/mL). Annexin V/propidium iodide (PI) staining assay suggested partial apoptosis induction in parasites by C. fistula to exert its antileishmanial activity. Here, for the first time, we have shown the antileishmanial potential of C. fistula leaves. Overall, our results could open new insight for an affordable and natural antileishmanial with high efficacy and less toxicity. |
---|---|
AbstractList | Cassia
fistula
has a wide array
of biologically active and therapeutically important class of compounds.
Leishmania donovani
important drug targets, sterol
24-c methyltransferase (
Ld
SMT), trypanothione reductase
(
Ld
TR), pteridine reductase (
Ld
PTR1),
and nucleoside hydrolase (
Ld
NH), were modelled, and
molecular docking was performed against the abundant phytochemicals
of its leaf extract. Molecular docking results provided the significant
prima facie evidence of the leaf extract to have antileishmanial potential.
To confirm this, we performed
in vitro
antileishmanial
and cytotoxicity assays. Methanolic extract of
C. fistula
leaves showed growth inhibition and proliferation of
L. donovani
promastigote with an IC
50
value
of 43.31 ± 4.202 μg/mL. It also inhibited the growth of
intra-macrophagic amastigotes with an IC
50
value of 80.76
± 3.626 μg/mL.
C. fistula
extract was found cytotoxic at a very high concentration on human
macrophages (CC
50
= 626 ± 39 μg/mL). Annexin
V/propidium iodide (PI) staining assay suggested partial apoptosis
induction in parasites by
C. fistula
to exert its antileishmanial activity. Here, for the first time,
we have shown the antileishmanial potential of
C. fistula
leaves. Overall, our results could open new insight for an affordable
and natural antileishmanial with high efficacy and less toxicity. has a wide array of biologically active and therapeutically important class of compounds. important drug targets, sterol 24-c methyltransferase ( SMT), trypanothione reductase ( TR), pteridine reductase ( PTR1), and nucleoside hydrolase ( NH), were modelled, and molecular docking was performed against the abundant phytochemicals of its leaf extract. Molecular docking results provided the significant prima facie evidence of the leaf extract to have antileishmanial potential. To confirm this, we performed antileishmanial and cytotoxicity assays. Methanolic extract of leaves showed growth inhibition and proliferation of promastigote with an IC value of 43.31 ± 4.202 μg/mL. It also inhibited the growth of intra-macrophagic amastigotes with an IC value of 80.76 ± 3.626 μg/mL. extract was found cytotoxic at a very high concentration on human macrophages (CC = 626 ± 39 μg/mL). Annexin V/propidium iodide (PI) staining assay suggested partial apoptosis induction in parasites by to exert its antileishmanial activity. Here, for the first time, we have shown the antileishmanial potential of leaves. Overall, our results could open new insight for an affordable and natural antileishmanial with high efficacy and less toxicity. Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol 24-c methyltransferase (LdSMT), trypanothione reductase (LdTR), pteridine reductase (LdPTR1), and nucleoside hydrolase (LdNH), were modelled, and molecular docking was performed against the abundant phytochemicals of its leaf extract. Molecular docking results provided the significant prima facie evidence of the leaf extract to have antileishmanial potential. To confirm this, we performed in vitro antileishmanial and cytotoxicity assays. Methanolic extract of C. fistula leaves showed growth inhibition and proliferation of L. donovani promastigote with an IC50 value of 43.31 ± 4.202 μg/mL. It also inhibited the growth of intra-macrophagic amastigotes with an IC50 value of 80.76 ± 3.626 μg/mL. C. fistula extract was found cytotoxic at a very high concentration on human macrophages (CC50 = 626 ± 39 μg/mL). Annexin V/propidium iodide (PI) staining assay suggested partial apoptosis induction in parasites by C. fistula to exert its antileishmanial activity. Here, for the first time, we have shown the antileishmanial potential of C. fistula leaves. Overall, our results could open new insight for an affordable and natural antileishmanial with high efficacy and less toxicity. |
Author | Alouffi, Abdulaziz S Tabrez, Shams Rub, Abdur Ali, Rahat Alshehri, Bader Mohammed Alshammari, Fahdah Ayed Bin Dukhyil, Abdul Aziz Alaidarous, Mohammed A Rahman, Fazlur Banawas, Saeed |
AuthorAffiliation | Infection and Immunity Lab , Department of Biotechnology Health and Basic Sciences Research Center Department of Biomedical Sciences Majmaah University Oregon State University College of Sciences and Literature Microbiology Department of Medical Laboratory Sciences, College of Applied Medical Sciences |
AuthorAffiliation_xml | – name: Infection and Immunity Lab , Department of Biotechnology – name: Department of Biomedical Sciences – name: Oregon State University – name: Health and Basic Sciences Research Center – name: Department of Medical Laboratory Sciences, College of Applied Medical Sciences – name: Majmaah University – name: College of Sciences and Literature Microbiology |
Author_xml | – sequence: 1 givenname: Shams surname: Tabrez fullname: Tabrez, Shams organization: Infection and Immunity Lab , Department of Biotechnology – sequence: 2 givenname: Fazlur surname: Rahman fullname: Rahman, Fazlur organization: Infection and Immunity Lab , Department of Biotechnology – sequence: 3 givenname: Rahat surname: Ali fullname: Ali, Rahat organization: Infection and Immunity Lab , Department of Biotechnology – sequence: 4 givenname: Abdulaziz S surname: Alouffi fullname: Alouffi, Abdulaziz S – sequence: 5 givenname: Bader Mohammed surname: Alshehri fullname: Alshehri, Bader Mohammed organization: Department of Medical Laboratory Sciences, College of Applied Medical Sciences – sequence: 6 givenname: Fahdah Ayed surname: Alshammari fullname: Alshammari, Fahdah Ayed organization: College of Sciences and Literature Microbiology – sequence: 7 givenname: Mohammed A surname: Alaidarous fullname: Alaidarous, Mohammed A organization: Majmaah University – sequence: 8 givenname: Saeed surname: Banawas fullname: Banawas, Saeed organization: Oregon State University – sequence: 9 givenname: Abdul Aziz surname: Bin Dukhyil fullname: Bin Dukhyil, Abdul Aziz organization: Majmaah University – sequence: 10 givenname: Abdur orcidid: 0000-0003-1301-0761 surname: Rub fullname: Rub, Abdur email: arub@jmi.ac.in organization: Infection and Immunity Lab , Department of Biotechnology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33521470$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctOIzEQRS0E4hHYs0L9AQT87McGKYpgAEUaFrC2qt3lxFF3G9kOgr_HTADBYlYuue49Zdc9IrujH5GQU0YvGOXsEkz0Ay7hghqqSt7skEMuKzplQordH_UBOYlxTSllZc1rXu6TAyEUZ7l_SO5nMWKMA46p8LZIKyxmY3I9urgaYHTQFw8-5e5HlQVziNFBYV1Mmx6KBYItrl9TAJOOyZ6FPuLJ5zkhTzfXj_Pb6eLvn7v5bDEFqao0lRV01LRlrWorTWW54q3itm2VqlSDvKlFZduuBGOkFQhVLUUNaBpJS6ZEJSbkbsvtPKz1c3ADhDftwel_Fz4sNYTkTI-al6XNGOSmlZJhA0ZSbqCDhqFoGc2sqy3redMO2Jn80QD9L-jvzuhWeulfdH4Va_JyJ4RuASb4GAPaby-j-iMm_RWT_owpW85-zvw2fIWSBedbQbbqtd-EMa_z_7x3NTyh3g |
CitedBy_id | crossref_primary_10_1016_j_biopha_2021_112156 crossref_primary_10_1007_s11756_024_01656_y crossref_primary_10_1002_jcb_29944 crossref_primary_10_1016_j_biopha_2021_112240 crossref_primary_10_1590_s2175_97902022e21306 crossref_primary_10_1002_ddr_21820 crossref_primary_10_3389_fphar_2022_953352 crossref_primary_10_1016_j_heliyon_2022_e10251 |
Cites_doi | 10.1038/s41564-018-0154-2 10.1021/jm900185q 10.1093/cid/cis474 10.1016/j.vaccine.2009.02.079 10.1007/BF00228148 10.1023/A:1006784224191 10.1016/j.jss.2005.08.025 10.1002/jcb.26433 10.1002/jsfa.7578 10.1016/j.exppara.2008.05.005 10.1093/jmedent/30.4.699 10.1371/journal.pone.0035671 10.1186/1758-2946-3-33 10.1006/jmbi.1993.1626 10.1371/journal.pone.0221331 10.3389/fimmu.2014.00273 10.1042/BSR20201256 10.1111/mmi.14139 10.13172/2054-4057-1-1-1119 10.1007/978-1-4939-2269-7_19 10.1017/S0031182011001120 10.5962/bhl.title.137025 10.1021/ja00051a040 10.1371/journal.pntd.0002536 10.5530/pj.2011.26.11 10.1016/j.bjp.2018.04.013 10.1016/j.ijantimicag.2018.12.011 10.3389/fimmu.2014.00193 10.4103/2231-4040.79814 10.1093/nar/gkn860 10.1002/(SICI)1099-1573(199812)12:8<576::AID-PTR354>3.0.CO;2-# 10.4103/0974-8490.157956 10.3390/molecules22010058 10.1016/j.ijpara.2004.10.019 10.1002/jcc.21334 10.1002/9780470514009.ch2 10.3390/nu8020090 |
ContentType | Journal Article |
Copyright | 2021 The
Authors. Published by American
Chemical Society 2021 The Authors. Published by American Chemical Society. 2021 The Authors. Published by American Chemical Society 2021 The Authors |
Copyright_xml | – notice: 2021 The Authors. Published by American Chemical Society – notice: 2021 The Authors. Published by American Chemical Society. – notice: 2021 The Authors. Published by American Chemical Society 2021 The Authors |
DBID | N~. NPM AAYXX CITATION 5PM DOA |
DOI | 10.1021/acsomega.0c05629 |
DatabaseName | American Chemical Society (ACS) Open Access PubMed CrossRef PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: N~. name: American Chemical Society (ACS) Open Access url: https://pubs.acs.org sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 2470-1343 |
EndPage | 2327 |
ExternalDocumentID | oai_doaj_org_article_266fcc4e2cb441e9ac402cada91e3b10 10_1021_acsomega_0c05629 33521470 a665111763 |
Genre | Journal Article |
GroupedDBID | 53G ABUCX ACS ADACO ADBBV AFEFF ALMA_UNASSIGNED_HOLDINGS BCNDV EBS GROUPED_DOAJ HYE N~. OK1 RPM VF5 AAFWJ AAHBH AFPKN AOIJS M~E NPM AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-a457t-47ad0cb6858f4c7f252b52fbb55759e29837fbd6acc4f3ea78438aec940615373 |
IEDL.DBID | RPM |
ISSN | 2470-1343 |
IngestDate | Fri Oct 04 13:12:35 EDT 2024 Tue Sep 17 21:11:39 EDT 2024 Fri Aug 23 03:39:56 EDT 2024 Sat Sep 28 08:26:05 EDT 2024 Thu Jan 28 04:14:15 EST 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | 2021 The Authors. Published by American Chemical Society. This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a457t-47ad0cb6858f4c7f252b52fbb55759e29837fbd6acc4f3ea78438aec940615373 |
ORCID | 0000-0003-1301-0761 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841934/ |
PMID | 33521470 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_266fcc4e2cb441e9ac402cada91e3b10 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7841934 crossref_primary_10_1021_acsomega_0c05629 pubmed_primary_33521470 acs_journals_10_1021_acsomega_0c05629 |
ProviderPackageCode | ACS ABUCX AFEFF VF5 N~. |
PublicationCentury | 2000 |
PublicationDate | 2021-01-26 |
PublicationDateYYYYMMDD | 2021-01-26 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-26 day: 26 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | ACS omega |
PublicationTitleAlternate | ACS Omega |
PublicationYear | 2021 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref9/cit9 Thirumal M. (ref13/cit13) 2012; 1 Castro-Lopez C. (ref15/cit15) 2018; 3 ref6/cit6 ref3/cit3 ref18/cit18 Rappé A. K. (ref36/cit36) 1992; 114 ref25/cit25 ref16/cit16 ref29/cit29 Kumar K. (ref12/cit12) 2017; 3 ref32/cit32 ref23/cit23 ref39/cit39 ref14/cit14 Khan I. (ref43/cit43) 2005 ref8/cit8 ref5/cit5 ref31/cit31 ref2/cit2 Searo W. (ref4/cit4) 2005 ref34/cit34 ref37/cit37 ref40/cit40 ref20/cit20 Vasudevan D. T. (ref11/cit11) 2009; 7 ref10/cit10 ref26/cit26 Monzote L. (ref17/cit17) 2016; 10 ref35/cit35 ref19/cit19 ref21/cit21 Trott O. (ref28/cit28) 2010; 31 ref42/cit42 Dallakyan S. (ref27/cit27) 2015; 1263 ref41/cit41 ref22/cit22 ref33/cit33 ref30/cit30 ref1/cit1 ref24/cit24 ref38/cit38 ref44/cit44 ref7/cit7 |
References_xml | – ident: ref1/cit1 doi: 10.1038/s41564-018-0154-2 – ident: ref23/cit23 doi: 10.1021/jm900185q – ident: ref5/cit5 doi: 10.1093/cid/cis474 – ident: ref25/cit25 doi: 10.1016/j.vaccine.2009.02.079 – ident: ref32/cit32 doi: 10.1007/BF00228148 – ident: ref9/cit9 doi: 10.1023/A:1006784224191 – ident: ref14/cit14 doi: 10.1016/j.jss.2005.08.025 – ident: ref34/cit34 doi: 10.1002/jcb.26433 – volume-title: Medicinal and Aromatic Plants of India year: 2005 ident: ref43/cit43 contributor: fullname: Khan I. – ident: ref16/cit16 doi: 10.1002/jsfa.7578 – ident: ref22/cit22 doi: 10.1016/j.exppara.2008.05.005 – ident: ref2/cit2 doi: 10.1093/jmedent/30.4.699 – ident: ref3/cit3 doi: 10.1371/journal.pone.0035671 – ident: ref35/cit35 doi: 10.1186/1758-2946-3-33 – ident: ref31/cit31 doi: 10.1006/jmbi.1993.1626 – ident: ref37/cit37 doi: 10.1371/journal.pone.0221331 – volume: 3 start-page: 38 year: 2017 ident: ref12/cit12 publication-title: Int. J. Pharm. Chem. Res. contributor: fullname: Kumar K. – volume: 1 start-page: 43 year: 2012 ident: ref13/cit13 publication-title: Crit. Rev. Pharm. Sci. contributor: fullname: Thirumal M. – ident: ref26/cit26 doi: 10.3389/fimmu.2014.00273 – ident: ref29/cit29 doi: 10.1042/BSR20201256 – ident: ref24/cit24 doi: 10.1111/mmi.14139 – ident: ref38/cit38 doi: 10.13172/2054-4057-1-1-1119 – volume: 1263 start-page: 243 year: 2015 ident: ref27/cit27 publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-2269-7_19 contributor: fullname: Dallakyan S. – ident: ref7/cit7 doi: 10.1017/S0031182011001120 – volume: 7 start-page: 2363 year: 2009 ident: ref11/cit11 publication-title: Int. J. Chem. Sci. contributor: fullname: Vasudevan D. T. – ident: ref42/cit42 doi: 10.5962/bhl.title.137025 – volume: 114 start-page: 10024 year: 1992 ident: ref36/cit36 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00051a040 contributor: fullname: Rappé A. K. – ident: ref6/cit6 doi: 10.1371/journal.pntd.0002536 – ident: ref44/cit44 doi: 10.5530/pj.2011.26.11 – ident: ref18/cit18 doi: 10.1016/j.bjp.2018.04.013 – volume-title: Regional Strategic Framework for Elimination of Kala-azar from South-East Asia Region (2005–2015) year: 2005 ident: ref4/cit4 contributor: fullname: Searo W. – volume: 10 start-page: 269 year: 2016 ident: ref17/cit17 publication-title: Rec. Nat. Prod. contributor: fullname: Monzote L. – ident: ref30/cit30 doi: 10.1016/j.ijantimicag.2018.12.011 – ident: ref40/cit40 doi: 10.3389/fimmu.2014.00193 – ident: ref10/cit10 doi: 10.4103/2231-4040.79814 – ident: ref33/cit33 doi: 10.1093/nar/gkn860 – volume: 3 start-page: 1477 year: 2018 ident: ref15/cit15 publication-title: Clin. Oncol. contributor: fullname: Castro-Lopez C. – ident: ref41/cit41 doi: 10.1002/(SICI)1099-1573(199812)12:8<576::AID-PTR354>3.0.CO;2-# – ident: ref8/cit8 doi: 10.4103/0974-8490.157956 – ident: ref21/cit21 doi: 10.3390/molecules22010058 – ident: ref20/cit20 doi: 10.1016/j.ijpara.2004.10.019 – volume: 31 start-page: 455 year: 2010 ident: ref28/cit28 publication-title: J. Comput. Chem. doi: 10.1002/jcc.21334 contributor: fullname: Trott O. – ident: ref39/cit39 doi: 10.1002/9780470514009.ch2 – ident: ref19/cit19 doi: 10.3390/nu8020090 |
SSID | ssj0001682826 |
Score | 2.2513418 |
Snippet | Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol... has a wide array of biologically active and therapeutically important class of compounds. important drug targets, sterol 24-c methyltransferase ( SMT),... Cassia fistula has a wide array of biologically active and therapeutically important class of compounds. Leishmania donovani important drug targets, sterol... |
SourceID | doaj pubmedcentral crossref pubmed acs |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2318 |
SummonAdditionalLinks | – databaseName: ACS Journals dbid: ACS link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELbYcti98NxHl4dygAOHdBPbefhYqlZVBQgJKvUWjR3PbgWbrEgqIX79jtP0ERah3qLETvwYZ77xjL9h7B23cYhagp-mggyUVKU-2BR9RMIaqA2aZh_y85d4OpezRbTY0eT87cHn4RWYqry11zAIjFPW6og95i6A0MGg0bfdfkpMtkOTXY3LJPBDIUXrlfzXS5wuMlVHFzWU_Xt6qBsjuad0Jk_X2YuqhqvQxZr8GKxqPTB_HjI5HtCfZ-xJiz294VpYnrNHtnjBjkeblG8v2Wy45en0SvQIG3rDoqb_xrK6cTwZVPlrWbv4IrqiAiNC3kvwkKqvfoL3yQJ649-1O3h1yuaT8ffR1G-TLfggo6T2ZQJ5YLSjo0dpEuQR1xFHrSOXwtNyRZYs6jwGYyQKC0kqRQrWKIcIIpGIM9YrysJeMI_nGhU3kEsBZFBJneQWlIrQiIDbQPbZexqErF0sVdb4wXmYbUYma0emzz5spie7W3Nv_KfsRzd_23KONbu5QUOftYswIzCC1HzLjSYUaBUYsp6pnaBCK3QY9Nn5etK3r3En0kKSpz5LOuLQ-U73SbG8aVi6nUNXCXl5YGdfsRPuwmWC0Ofxa9arf63sG8I7tX7bCPo92Dj9Bw priority: 102 providerName: American Chemical Society – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELZQF1gQb8pLGWBgCCS28_BYKqqqAsRAJbbo7PhoJUgRTSV-PuckrZoFFrYosRPrO0ffnX3-jrFLbuMQtQQ_TQUFKKlKfbAp-ojka6A2aKp1yMeneDiWo9foda3Ul8sJq-WBa-BuiUDQGGm50cTcVoGhiMdADiq0QjeHq8JoLZiqVldiiiT4cl-SeOwWzHz2Yd_gJjCO85VjIzNvsVEl2r_GRO0syTXaGeyw7cZf9Hr1OHfZhi322GZ_WaZtn416K21Nb4Ye-XNeryjpX5_OJ07bgjo_z0qXE0RX1KBP3vIUPKTui3fwHiygd_9dusNSB2w8uH_pD_2mQIIPMkpKXyaQB0Y7CXmUJkEecR1x1DpyZTctVxR9os5jIABRWEhSKVKwRjkWj0QiDlmnmBX2mHk816gcrlIABUFSJ7kFpSI0IuA2kF12RXBlzQSfZ9XeNQ-zJaxZA2uXXS8BzT5rvYxf2t45xFftnNJ1dYPsnzX2z_6yf5cd1WZavcadIgtlQk-SlgFb32k_KaaTSlnbbcIqIU_-Y2CnbIu7_Jcg9Hl8xjrl18KekwNT6otqrv4AwXjx3g priority: 102 providerName: Directory of Open Access Journals |
Title | Assessment of the Antileishmanial Potential of Cassia fistula Leaf Extract |
URI | http://dx.doi.org/10.1021/acsomega.0c05629 https://www.ncbi.nlm.nih.gov/pubmed/33521470 https://pubmed.ncbi.nlm.nih.gov/PMC7841934 https://doaj.org/article/266fcc4e2cb441e9ac402cada91e3b10 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZYLu0Flb5YWlY5tAcO2U1s5-HjEoEQKgipIHGLxo4HVmITxAapJ347Y2-y2lw49BJFsZ1YMxPNN_b4G8Z-cZvGqCWEeS4oQMlVHoLNMUQkrIHaoPHrkJdX6fmtvLhL7nZY0p-F8Un7Ri-m9eNyWi8efG7l09LM-jyx2fVl4fbKlJCzERtlQmyF6H5hJaUggvdbkuTCZmBWzdLewzQyzt07olB30iiWrkLxiFoHPslT92_5o2Gu5JbzOfvE9jrUGMzXs9tnO7b-zD4UfbG2L-xivmHYDBoMCNUF87qlP36xenAMFzT4umldZhDdUYeCMPMCAqThL48Q_LGAwem_1h2Z-spuz05vivOwK5MQgkyyNpQZVJHRjkgepcmQJ1wnHLVOXPFNyxXFoKirFIyRKCyQ9EQO1ijnyxORiW9st25qe8ACXmlU3EAlBVAoJHVWWVAqQSMibiM5Zr9JXGVn5qvS72DzuOwlXHYSHrPjXqDl05o1452-J07im36O79o_aJ7vy07rJcEIpOlbbjThN6vAUNxL8wQVW6HjaMy-r9W0eU2v4THLBgocfGfYQubm-bU78zr875E_2EfuUl-iOOTpT7bbPr_YI8IurZ4Qdi_-TnzkT9er1-nEW-8b4zj0WA |
link.rule.ids | 230,315,733,786,790,870,891,2115,2782,27109,27113,27957,27958,53827,53829,57093,57117,57143,57167 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3PT9swFH5icGCXAftZGJDDdtghXWI7dXzsKlBhBU0bSNwi2_GDals6Lak07a_n2U0LmSa03SLHduzn57zv2c-fAd4wN0jRCB3nOScHJVd5rF2OMSJhDTQWbViHPDsfjC_F6VV2tQbp8iwMNaKmmuqwiX_HLpC-p7TZd3et-4n1Nls9go1Mkjvu0dDoy92yyoBciHDJGhMyiVMueLs5-bdKvEmydcckBeb-e-aoGyp5z_Ycb8HnVatDyMnX_rwxffv7D0LH_-rWNjxpkWg0XKjODqy56ilsjpYXwD2D0-GKtTOaYURIMRpWDf1FpvWNZ82gwp9mjY82oifKMCIcPtURUvH5Nx1NnMbo6Ffjj2E9h8vjo4vROG6vXoi1yGQTC6nLxBpPTo_CSmQZMxlDYzJ_oadjivxaNOVAWyuQOy1zwXPtrPL4IOOSv4D1ala5VxCx0qBiVpeCa3KvhJGl00plaHnCXCJ68JaEULRTpy7CrjhLi6VkilYyPXi3HKXix4KJ44G8H_wwrvJ5Du2QQOIv2ilZEDRBar5j1hAmdEpb8qWpnVqljps06cHLxdivqvHn01JSqx7IjlZ0vtN9U01vAme3395VXOz-Y2cPYXN8cTYpJifnH_fgMfOBNImPPXwN683PudsnJNSYg6D7t3OqBXo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VIkEvUF7tAoUc4MAh28SPJD4u265KKVUlKOotsh0PXbXNViQrIX49Y292aSqE4BY5tmN77Mw3HvsbgDfMZSkaoeOi4GSgFKqItSswRiSsgcaiDfuQn46zg1NxeCbP1kAu78JQIxqqqQlOfL-qryvsGAbSXUqfXblvephYr7fVHbgrffxuj4jGn39vrWRkRoRAa0zkSZxywTsH5Z8q8WrJNj21FNj7b6ik_nHJG_pn8hC-rloejp1cDOetGdqft0gd_7trm_CgQ6TRaDGFHsGaqx_D_fEyENwTOByt2DujGUaEGKNR3dLfZNqce_YMKnwya_2pI3qiDGPC41MdIRWfX-royGmM9n-0_jrWUzid7H8ZH8RdCIZYC5m3sch1lVjjSepR2ByZZEYyNEb6wJ6OKbJv0VSZtlYgdzovBC-0s8rjBMlz_gzW61nttiFilUHFrK4E12RmCZNXTisl0fKEuUQM4C0NQtktoaYM3nGWlsuRKbuRGcC7paTK6wUjx1_yvveiXOXzXNohgURQdkuzJIiC1HzHrCFs6JS2ZFNTO7VKHTdpMoCthfxX1fh7ailNrQHkvZnR-07_TT09D9zd3s2ruHj-j519DfdO9ibl0Yfjjy9gg_nzNEkas-wlrLff526HAFFrXoXp_wu74Qf7 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+the+Antileishmanial+Potential+of+Cassia+fistula+Leaf+Extract&rft.jtitle=ACS+omega&rft.au=Tabrez%2C+Shams&rft.au=Rahman%2C+Fazlur&rft.au=Ali%2C+Rahat&rft.au=Alouffi%2C+Abdulaziz+S&rft.date=2021-01-26&rft.eissn=2470-1343&rft.volume=6&rft.issue=3&rft.spage=2318&rft_id=info:doi/10.1021%2Facsomega.0c05629&rft_id=info%3Apmid%2F33521470&rft.externalDocID=33521470 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2470-1343&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2470-1343&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2470-1343&client=summon |